Evidence mapPaperPMID 42016343Full record

ReviewInternational journal of nanomedicine2026

Nanoporous Materials in Biomedical Research: Progress and Potential.

Fangli Gao, Jianming Xing, Chengzhong Yu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fangli GaoSchool of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan, People's Republic of China.
Jianming XingAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-4785-3268
Chengzhong YuAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0003-3707-0785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoporous materials have been the focus of considerable attention due to their unique structural and physicochemical properties and a diverse range of applications, such as drug delivery, biosensing and tissue engineering in biomedical fields. Distinct from existing reviews that primarily focus on material synthesis or single application scenarios, this review provides an integrated and mechanism-oriented overview of nanoporous nanomaterials for biomedical use. This review focuses on the biomedical applications of nanoporous nanomaterials, including inorganic, organic, and hybrid nanoporous materials. Initially, the definition and classification of nanoporous materials are introduced, followed by an overview of their significance in biomedical fields. Importantly, this review systematically summarizes the interactions between nanoporous materials and biological systems at the molecular, cellular, and tissue levels, highlighting the role of nanoporosity in governing biological responses. Further, the biomedical application of nanoporous materials in smart drug and gene delivery, tissue repair and regeneration, immunomodulation, cancer therapy and theranostics are summarized. Finally, key challenges related to biosafety, long-term stability, biodegradation, immune interactions, and clinical translation are critically analyzed, together with emerging trends and future research directions. This review provides an entry-level reference specifically for young researchers working in an exciting interdisciplinary area of nanoporous materials and medicine.

Indexed as

Biocompatible MaterialsBiomedical ResearchNanoporesNanostructuresAnimalsDrug Delivery SystemsHumansNanomedicineTissue EngineeringBiocompatible Materialsbiomedical applicationbiomedical fieldsdrug delivery systemsinterdisciplinary areamechanistic interactionnanoporous materials

Identifiers

PMID42016343
PMCPMC13092569

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.